Join our community!
We believe in entrepreneurship in Haifa, and invite you to share a part of our journey
We believe in entrepreneurship in Haifa, and invite you to share a part of our journey
Join our newsletter to be updated
on everything that happens in
entrepreneurship field in Haifa
Promise not to send spam!
You can unsubscribe any time
Preserved Ejection Fraction Heart Failure Treatment
CorAssist is a clinical-stage medical device company developing therapeutic products for treating heart failure with preserved ejection fraction. The companys proprietary technology enables the implantation of a device that directly improves cardiac diastolic function.
CORolla is an elastic, self-expanding, internal, spring-like device implanted inside the left ventricle through a transapical or percutaneous procedure. The device assists diastolic function by improving diastolic dynamics and filling performance, and does not require an external power source.
ImCardia, the companys first product, is an elastic, self-expanding device that is attached to the external left ventricular surface through a simple off-pump procedure.